Renxi Wang Selected Research

Mucin-3

1/2018	Negative regulation of Nod-like receptor protein 3 inflammasome activation by T cell Ig mucin-3 protects against peritonitis.
1/2017	Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2.
3/2013	T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response.
12/2012	Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis.
2/2010	Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renxi Wang Research Topics

Disease

12	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2008
7	Inflammation (Inflammations) 01/2019 - 09/2013
7	Colitis 01/2019 - 02/2010
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2010 - 04/2005
6	Neoplasms (Cancer) 01/2020 - 02/2014
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2014 - 02/2010
5	Sepsis (Septicemia) 03/2013 - 04/2010
4	Infections 10/2021 - 02/2015
3	Multiple Sclerosis 01/2022 - 01/2015
3	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 02/2014
3	Cytokine Release Syndrome 01/2018 - 12/2007
3	Weight Loss (Weight Reduction) 01/2012 - 03/2011
2	Vesicular Stomatitis 10/2021 - 01/2021
2	Necrosis 02/2021 - 09/2011
2	Multiple Myeloma 01/2020 - 10/2016
2	Proteinuria 01/2020 - 01/2018
2	Carcinogenesis 01/2019 - 02/2014
2	Lung Injury 01/2018 - 02/2015
2	Splenomegaly 01/2018 - 09/2013
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2015 - 05/2014
1	Rheumatoid Arthritis 05/2022
1	COVID-19 01/2022
1	Low Back Pain (Lumbago) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Peritonitis 01/2018
1	Poisoning 01/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Acute Lung Injury 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Uveitis 01/2017
1	Immune System Diseases (Immune Disorders) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	B-Cell Leukemia (Leukemia, B Cell) 10/2016
1	Lung Diseases (Lung Disease) 05/2015
1	Viral Pneumonia 02/2015
1	Cerebral Infarction 02/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2015

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 02/2021 - 02/2008
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2011
5	Mucin-3IBA 01/2018 - 02/2010
5	Complement System Proteins (Complement)IBA 05/2015 - 10/2010
4	InterleukinsIBA 02/2021 - 09/2011
4	Interleukin-12 (IL 12)IBA 01/2017 - 01/2013
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
3	AntibodiesIBA 01/2018 - 03/2011
3	B-Cell Activating FactorIBA 01/2017 - 01/2015
3	Immunoglobulin G (IgG)IBA 01/2015 - 02/2014
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2013 - 09/2011
3	Complement C5a (Complement 5a)IBA 07/2011 - 04/2010
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2022 - 01/2022
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2020 - 07/2011
2	AutoantibodiesIBA 01/2020 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2017
2	MucinsIBA 01/2020 - 03/2013
2	InterferonsIBA 02/2019 - 09/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017 - 02/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 03/2016
2	Biological ProductsIBA 05/2015 - 12/2007
2	TACI receptor-IgG Fc fragment fusion proteinIBA 01/2015 - 05/2014
2	LigandsIBA 02/2014 - 12/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013 - 01/2012
2	Dextran SulfateIBA 09/2013 - 01/2012
2	Type I Tumor Necrosis Factor ReceptorsIBA 09/2013 - 01/2012
2	Type II Tumor Necrosis Factor ReceptorsIBA 09/2013 - 09/2011
2	Peroxidase (Myeloperoxidase)IBA 01/2012 - 09/2011
2	Anaphylatoxin C5a ReceptorIBA 07/2011 - 03/2011
2	Sulfonic AcidsIBA 03/2011 - 02/2010
2	Interleukin-17 (Interleukin 17)IBA 04/2010 - 02/2010
2	Transforming Growth Factor beta (TGF-beta)IBA 02/2010 - 09/2009
2	AutoantigensIBA 01/2008 - 04/2005
1	25-hydroxyvitamin DIBA 01/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2021
1	SolutionsIBA 01/2021
1	pristane (pristan)IBA 01/2020
1	vilobelimabIBA 01/2018
1	aluminum sulfate (alum)IBA 01/2018
1	NLR ProteinsIBA 01/2018
1	ParaquatIBA 01/2018
1	InflammasomesIBA 01/2018
1	Interleukin-12 Subunit p35IBA 01/2017
1	Cytotoxins (Cytolysins)IBA 01/2017
1	metabotropic glutamate receptor 3 (mGluR3)IBA 10/2016
1	Indicators and Reagents (Reagents)IBA 10/2016
1	Oxidants (Oxidizing Agents)IBA 05/2015
1	Interleukin-15 (Interleukin 15)IBA 05/2014
1	CalciumIBA 02/2014
1	Glycoproteins (Glycoprotein)IBA 02/2014
1	Cyclophilins (Cyclophilin)IBA 02/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014
1	ChemokinesIBA 09/2013
1	Dextrans (Dextran)FDA Link 12/2012
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 12/2012
1	Galectins (Galectin)IBA 12/2012
1	Monocyte Chemoattractant ProteinsIBA 09/2011

Therapy/Procedure

3	Therapeutics 01/2018 - 04/2005
3	Punctures 01/2013 - 04/2010
3	Ligation 01/2013 - 04/2010
1	Oral Administration 09/2013